908 Devices Inc. (MASS)
NASDAQ: MASS · Real-Time Price · USD
11.49
+0.14 (1.23%)
At close: Oct 23, 2026, 4:00 PM EDT
11.53
+0.04 (0.35%)
After-hours: Oct 23, 2026, 5:24 PM EDT
908 Devices Revenue
908 Devices had revenue of $16.07M in the quarter ending June 30, 2026, with 23.31% growth. This brings the company's total for the last twelve months to $60.84M, up 4.62% year-over-year. In the year 2025, 908 Devices had annual revenue of $56.20M with 17.70% growth. That makes 908 Devices the 26,484th largest company in the world by revenue and 3,635th in the United States.
Revenue (ttm)
$60.84M
Revenue Growth
+4.62%
P/S Ratio
7.81
Revenue / Employee
$353,721
Employees
172
Market Cap
474.92M
Revenue by Geography
- United States 41.25M 73.4%
- Europe, Middle East and Africa 10.43M 18.6%
- Asia Pacific 3.00M 5.3%
- Americas Other 1.53M 2.7%
Fiscal year ended Dec 31, 2025 See the full 908 Devices breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 56.20M | 8.45M | 17.70% |
| Dec 31, 2024 | 47.75M | -2.48M | -4.94% |
| Dec 31, 2023 | 50.23M | 3.38M | 7.21% |
| Dec 31, 2022 | 46.85M | 4.65M | 11.01% |
| Dec 31, 2021 | 42.21M | 15.31M | 56.93% |
| Dec 31, 2020 | 26.89M | 8.92M | 49.64% |
| Dec 31, 2019 | 17.97M | -4.08M | -18.51% |
| Dec 31, 2018 | 22.05M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Orthofix Medical | 833.19M |
| Tactile Systems Technology | 350.31M |
| Cerus | 221.55M |
| NeuroPace | 106.99M |
| Delcath Systems | 95.42M |
| Sight Sciences | 83.38M |
| AVITA Medical | 75.63M |
| BrainsWay | 60.70M |
MASS News
- 6 weeks ago - 908 Devices initiated with a Buy at Canaccord - TheFly
- 7 weeks ago - 908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium - Business Wire
- 1 month ago - 908 Devices Transcript: 17th Annual Midwest IDEAS Conference - Transcripts
- 1 month ago - 908 Devices Slides: 17th Annual Midwest IDEAS Conference - Filings
- 2 months ago - 908 Devices price target raised to $12 from $10 at Stifel - TheFly
- 2 months ago - 908 Devices price target raised to $13 from $11 at Roth Capital - TheFly
- 2 months ago - 908 Devices Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 2 months ago - 908 Devices to Present at the 17th Annual Midwest IDEAS Investor Conference - Business Wire